On December 18, 2025, markets awaited the release of the MBX Financial Report for the fourth quarter and full year of fiscal 2025 — a key milestone for MBX Biosciences, Inc. — a clinical-stage biotechnology company focused on precision peptide therapies for endocrine and metabolic disorders including hypoparathyroidism. MBX Biosciences is publicly traded under the ticker MBX stock on the…
On December 18, 2025, DMG Blockchain Solutions Inc. — a vertically integrated blockchain, digital asset services, and data center technology firm — released its audited fourth quarter and full-year 2025 earnings, sparking renewed investor interest in the DMGI stock. The DMGI Financial Report shows robust revenue growth, a dramatic expansion of operating metrics like hash rate and cash flow, and…
FuelCell Energy, Inc.(FCEL) — the U.S.-based renewable energy technology company celebrated for its carbonate fuel cell systems — delivered a compelling FCEL Financial Report on December 18, 2025, announcing its fourth quarter and full-year results for fiscal year 2025. The closely watched FuelCell Energy Earnings release reported double-digit revenue growth, a significant narrowing of losses, and a strategic realignment toward…
On December 17, 2025, ABM Industries Incorporated (NYSE: ABM) released its Q4 2025 financial results, revealing a mixed picture of record quarterly revenue growth, a significant earnings miss relative to consensus expectations, and updated guidance for fiscal 2026 that drew a cautious market reaction. ABM stock price experienced volatility as investors parsed revenue strength against weaker profit performance and earnings…